Articles tagged with: PTG121

Experimental antibody plus TLR7 agonist maintains viral suppression in monkeys

published: March, 07, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, International AIDS Conference , As Prevention , Conferences, Current Affairs, Treatment Guidelines -including when to start, Research, Health, International , Revolving Door, Treatment, Media, Guest Authors

Five of eleven treated animals still remained virally suppressed at six months. From AIDSmap, Liz Highleyman reports.

Experimental antibody plus TLR7 agonist maintains viral suppression in monkeys

Dan Barouch presenting at CROI 2018. Photo by Liz Highleyman Treatment with a broadly neutralising antibody plus an immune-stimulating drug led to long-term viral remission after interrupting antiretroviral therapy in a monkey study, according to data presented at the 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018) this week in Boston. Monkeys that received both the antibody, known as PGT121, and the TLR7 agonist GS-9620 maintained an undetectable viral load withou